Ocrelizumab jekiseni

Zvemukati

• Ocrelizumab jekiseni inoshandiswa kurapa vanhu vakuru vane dzakasiyana siyana dze multiple sclerosis (MS; chirwere umo tsinga dzisingashande nemazvo uye vanhu vanogona kuona kushaya simba, kupera simba, kurasikirwa kwekubatana kwemhasuru, uye matambudziko nemaonero, kutaura, uye kudzora kwedundira) kusanganisira:
• Usati wagamuchira ocrelizumab jekiseni,
• Ocrelizumab inogona kukonzera mhedzisiro. Udza chiremba wako kana chimwe chezviratidzo izvi chakanyanya kana kuti chisingaendi:
• Mimwe mhedzisiro inogona kuve yakakomba. Kana iwe ukasangana nechimwe chezviratidzo izvi kana izvo zvakanyorwa muchikamu CHENYAYA, fonera chiremba wako nekukurumidza kana kuwana kurapwa kwekukurumidzira:

Ocrelizumab jekiseni inoshandiswa kurapa vanhu vakuru vane dzakasiyana siyana dze multiple sclerosis (MS; chirwere umo tsinga dzisingashande nemazvo uye vanhu vanogona kuona kushaya simba, kupera simba, kurasikirwa kwekubatana kwemhasuru, uye matambudziko nemaonero, kutaura, uye kudzora kwedundira) kusanganisira:

• mafomu-epamberi mafomu (zviratidzo zvishoma nezvishoma zvinowedzera kuwedzera nekufamba kwenguva) zveMS,
• kiriniki yakasarudzika syndrome (CIS; nerve chiratidzo zviratidzo izvo zvinogara anopfuura maawa makumi maviri nemana),
• kudzokerazve-kuregedza mafomu (kosi yechirwere uko zviratidzo zvinopisa nguva nenguva), kana
• yechipiri inofambira mberi mafomu (kosi yechirwere uko kudzokazve kunoitika kazhinji).

Ocrelizumab mukirasi yemishonga inonzi monoclonal antibodies. Inoshanda nekumisa mamwe maseru ezvirwere zvemuviri kubva mukukonzera kukuvara.

Ocrelizumab jekiseni inouya semhinduro (mvura) inovejerwa mukati (mutsinga) nachiremba kana mukoti. Inowanzo kupihwa kamwe chete kwemavhiki maviri ekutanga maadhi maviri (pavhiki 0 nevhiki 2), uyezve infusions inopihwa kamwe pamwedzi mitanhatu.

Ocrelizumab jekiseni inogona kukonzeresa kuita kwakakomba panguva yekuwedzeredzwa uye kusvika kune zuva mushure mekugamuchira infusion. Iwe unogona kupihwa imwe mishonga yekurapa kana kubatsira kudzivirira maitiro kune ocrelizumab. Chiremba kana mukoti anozokutarisa zvakanyanya paunenge uchigamuchira kuzarirwa uye kweinenge 1 awa mushure kuti upe kurapwa kana paine zvimwe zvinokanganisa kumushonga. Chiremba wako anogona kumbomira kurapwa kwenguva pfupi kana zvachose kana kudzikisa dosi, kana iwe ukava nezvimwe zvinokanganisa. Udza chiremba wako kana mukoti kana iwe uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchinge uchiona kana chimwe cheichi chinotevera mukati kana mukati maawa 24 mushure mekupinzwa kwako: kukurumidza kuvava; mikoko; kutsvuka panzvimbo yejekiseni; kunetseka kufema kana kumedza; kukosora; kurira; mapundu; kunzwa kupera simba; kutsamwa kwehuro; kurwadziwa mumuromo kana pahuro; mweya wekufema; kuzvimba kwechiso, maziso, muromo, huro, rurimi, kana miromo; kutsvaira; kupindwa nechando; kuneta; kuneta; kurwadziwa nemusoro; dzungu; kusvotwa; kana kurova kwemoyo kumhanya. Fonera chiremba wako nekukasira kana tora nekukurumidza kurapwa kwekukurumidzira kana iwe ukawana chero cheizvi zviratidzo mushure mekunge wabva muhofisi yechiremba kana nzvimbo yekurapa.

Ocrelizumab inogona kubatsira kudzora akawanda sclerosis zviratidzo asi haivarape.Chiremba wako anokucherechedza zvakanyatsoona kuti ocrelizumab inoshanda sei kwauri. Zvakakosha kuudza chiremba wako kuti uri kunzwa sei panguva yekurapwa kwako.

Chiremba wako kana wemishonga achakupa iro gadziriro yeruzivo yemurwere (Gwaro Rekurapa) paunotanga kurapwa nejekiseni ye ocrelizumab uye nguva yega yega paunozadza mushonga wako. Verenga iwo ruzivo nokungwarira uye bvunza chiremba wako kana wemishonga kana iwe uine chero mibvunzo. Iwe unogona zvakare kushanyira Chikafu neDrug Administration (FDA) webhusaiti (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm)kana webhusaiti yemugadziri kuti utore Gwaro reMishonga.

Mushonga uyu unogona kupihwa zvimwe zvinoshandiswa; bvunza chiremba wako kana wemishonga kuti uwane rumwe ruzivo.

Usati wagamuchira ocrelizumab jekiseni,

• udza chiremba wako uye wemishonga kana uri weergoria kune ocrelizumab, chero mimwe mishonga, kana chero chinhu chinosanganiswa mujekiseni ye ocrelizumab. Kumbira wako wemishonga kuti uwane runyorwa rwezvigadzirwa.
• udza chiremba wako uye wemishonga kuti ndeipi imwe mishonga yekunyorera uye isina kunyoreswa, mavitamini, zvinowedzera zvinovaka muviri, uye mishonga yemakwenzi yauri kutora kana kuronga kutora. Ive neshuwa yekutaura mishonga inodzvinyirira immune immune yako seinotevera: corticosteroids inosanganisira dexamethasone, methylprednisolone (Medrol), uye prednisone (Rayos); cyclosporine (Gengraf, Neoral, Sandimmune); daclizumab (Zinbryta); fingolimod (Gilenya); mitoxantrone; natalizumab (Tysabri); tacrolimus (Astagraf, Prograf); kana teriflunomide (Aubagio). Chiremba wako angangoda kushandura madosi emishonga yako kana kukutarisisa nokungwarira mhedzisiro.
• udza chiremba wako kana iwe wakambove kana uine hepatitis B (HBV; hutachiona hunokanganisa chiropa uye hunogona kukonzera kukuvara kwechiropa kwakakomba kana gomarara rechiropa). Chiremba wako angangokuudza kuti usatore ocrelizumab.
• udza chiremba wako kana iwe uine chero hutachiona usati watanga kurapwa kwako neocrelizumab jekiseni.
• udza chiremba wako kana iwe uri nepamuviri, ronga kuve nepamuviri, kana uri kuyamwisa. Shandisa zvinobudirira kuberekwa panguva yekurapa kwako neocrelizumab uye kwemwedzi mitanhatu mushure mekupedzisira dosi. Kana iwe ukava nepamuviri iwe uchigamuchira ocrelizumab, fonera chiremba wako. Kana iwe ukatambira ocrelizumab jekiseni panguva yako yepamuviri, ive shuwa yekutaura nachiremba wemwana wako nezve izvi mushure mekunge mwana wako aberekwa. Mwana wako angangoda kunonoka kugamuchira mamwe majekiseni.
• udza chiremba wako kana wakambobaiwa nhomba kana kuti wakarongerwa kupihwa majekiseni. Iwe ungangoda kugamuchira mamwe marudzi ejekiseni kanokwana mavhiki mana zvisati zvaitika uye mamwe angangoita mavhiki maviri usati watanga kurapwa nejekiseni ye ocrelizumab. Hauna majekiseni pasina kutaura nachiremba wako panguva yekurapwa kwako.

Kunze kwekunge chiremba wako akakuudza neimwe nzira, ramba uchidya zvakajairika.

Kana iwe ukarasikirwa musangano kuti ugamuchire ocrelizumab, fonera chiremba wako nekukurumidza sezvinobvira kuti udzorezve nguva yako.

Ocrelizumab inogona kukonzera mhedzisiro. Udza chiremba wako kana chimwe chezviratidzo izvi chakanyanya kana kuti chisingaendi:

• kuzvimba kana kurwadziwa mumaoko, maoko, makumbo, kana tsoka
• manyoka

Mimwe mhedzisiro inogona kuve yakakomba. Kana iwe ukasangana nechimwe chezviratidzo izvi kana izvo zvakanyorwa muchikamu CHENYAYA, fonera chiremba wako nekukurumidza kana kuwana kurapwa kwekukurumidzira:

• fivha, kutonhora, kukosora, kana zvimwe zviratidzo zvehutachiona
• maronda emuromo
• shingles (kuputika kunogona kuitika kune vanhu vakave nehukuku munguva yakapfuura)
• maronda akakomberedza genital kana rectum
• hutachiona hweganda
• kushaya simba kune rumwe rutivi rwemuviri; kusindimara kwemaoko nemakumbo; maonero anochinja; shanduko mukufunga, ndangariro, uye maitiro; kuvhiringidzika; kana hunhu hunoshanduka

Ocrelizumab inogona kuwedzera njodzi yako yemamwe cancer, kusanganisira cancer yemazamu. Taura nachiremba wako nezve njodzi dzekugamuchira uyu mushonga.

Ocrelizumab inogona kukonzera mamwe mhedzisiro. Fonera chiremba wako kana uine chero matambudziko asina kujairika paunenge uchigamuchira mushonga uyu.

Kana iwe ukawana chakakomba mhedzisiro, iwe kana chiremba wako ungatumira chirevo kuchirongwa cheKudya neDrug Administration's (FDA) MedWatch Yakashata Chiitiko Chirongwa online (http://www.fda.gov/Safety/MedWatch) kana nefoni ( 1-800-332-1088).

Kana zvikaitika zvekudarika, fonera iyo chepfu yekudzora rubatsiro pa1-800-222-1222. Ruzivo rwunowanikwawo online pa https://www.poisonhelp.org/help. Kana munhu akabatwa akadonha, akabatwa nepfari, achinetseka kufema, kana kutadza kumutswa, pakarepo danaidza mabasa ekukurumidzira pa911.

Chengetedza zvese zvakagadzwa nachiremba wako uye murabhoritari. Chiremba wako acharaira mamwe marabhoritari ekuongorora usati uye panguva yekurapa kwako kuti utarise mhinduro yemuviri wako kune ocrelizumab jekiseni.

Kumbira wemishonga wako chero mibvunzo iwe unayo nezve ocrelizumab jekiseni.

Izvo zvakakosha kuti iwe uchengete yakanyorwa rondedzero yeese emushonga uye asiri ekunyora (pamusoro-e-pikisheni) mishonga yauri kutora, pamwe nezvimwe zvigadzirwa zvakaita sevhitamini, zvicherwa, kana zvimwe zvekuwedzera zvekudya. Iwe unofanirwa kuuya nerondedzero iyi iwe nguva imwe neimwe paunoshanyira chiremba kana kana iwe uchigamuchirwa kuchipatara. Izvo zvakare zvakakosha ruzivo kutakura newe kana zvikaitika zvechimbi-chimbi.

• Ocrevus^®